Cancer, Inflammation, and Insights from Ayurveda
Open Access
- 5 July 2012
- journal article
- review article
- Published by Hindawi Limited in Evidence-Based Complementary and Alternative Medicine
- Vol. 2012, 1-11
- https://doi.org/10.1155/2012/306346
Abstract
A recent, exciting discovery relates to the concept of “shared pathology” between cancer and metabolic syndrome. One major pathway common to cancer and metabolic syndrome is chronic inflammation, which is a major driving force in carcinogenesis. Indeed, chronic inflammation precedes most cancers and is considered a “hallmark” of the neoplastic process. We discuss molecular and biochemical evidence which links diet, obesity, abnormal lipid metabolism, and type 2 diabetes mellitus with chronic inflammation. We also explain how each of these factors is linked with biochemical aberrations of carcinogenesis and the prevalence and risk of cancer. While there are reliable biomarkers for chronic inflammation, there are few markers for a mechanistic link between early inflammation and digestive disorders. Discovery of such a marker could lead to identification of a new subtype of patients with digestive disorders that predispose them to cancer and/or metabolic syndrome. In this context, we discuss the ayurvedic concept of “Ama” which is thought to be a toxic, proinflammatory waste-product of improper digestion. We then develop hypotheses and outline preclinical and clinical experiments designed to prove whether “Ama” can serve as a novel and reliable biomarker that links abnormal digestive status, with the onset of chronic inflammation.Keywords
This publication has 52 references indexed in Scilit:
- The Complex Interplay Between Cholesterol and Prostate MalignancyUrologic Clinics of North America, 2011
- PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammationBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2011
- Lipid Peroxidation Modification of Protein Generates Nϵ-(4-Oxononanoyl)lysine as a Pro-inflammatory LigandOnline Journal of Public Health Informatics, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- A Transcriptional Signature and Common Gene Networks Link Cancer with Lipid Metabolism and Diverse Human DiseasesCancer Cell, 2010
- Farnesoid X receptor antagonizes nuclear factor κB in hepatic inflammatory responseJournal of Hepatology, 2008
- Cancer-related inflammationNature, 2008
- Variations in DNA elucidate molecular networks that cause diseaseNature, 2008
- The gut flora as a forgotten organEMBO Reports, 2006
- Nuclear factor-κB in cancer development and progressionNature, 2006